期刊文献+

奥氮平联合利培酮治疗难治性精神分裂症的应用效果分析 被引量:11

下载PDF
导出
摘要 目的:探讨难治性精神分裂症采用奥氮平与利培酮联合治疗的临床应用效果。方法:选择某院收治的24例难治性精神分裂症患者,以随机数字表法分为2组,每组12例,对照组行利培酮治疗,观察组行奥氮平与利培酮联合治疗,比较对照组与观察组临床治疗效果。结果:治疗前2组患者PANSS评分比较,差异无统计学意义(P>0.05),治疗后2组患者PANSS评分比较差异有统计学意义(P<0.05);观察组患者不良反应发生率低于对照组,临床有效率高于对照组,2组比较差异有统计学意义(P<0.05)。结论:奥氮平与利培酮联合治疗难治性精神分裂症,可改善患者阴性症状,降低不良反应,值得临床推广应用。
作者 黄木香 宋鑫
出处 《淮海医药》 CAS 2019年第2期182-183,共2页 Journal of Huaihai Medicine
  • 相关文献

参考文献11

二级参考文献70

  • 1于永涛,杨君宏,刘河.利培酮与奥氮平治疗难治性精神分裂症对照研究[J].临床研究,2014,22(9):73-74. 被引量:4
  • 2SUZUKI Y, SUGAI T, FUKUI N, et al. Differences in plasma prolactin levels in patients with schizophrenia treated on monotherapy with five second-generation antipsychotics [ J ].Sehizophr Res,2013,145(]-3) : 116- 119.
  • 3ASMAL L, FLEGAR S J, WANG J, et al. Qiletiapine versus other atypical antipsychotics for schizophrenia [ J ]. Cochrane Database Syst Rev, 2013 ( 11 ) : CD006625.
  • 4KRZYSTANEK M, KRUPKA-MATUSZCZYK I. An open, large,6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine [ J ]. Hum Psychopharmacol, 2011,26 ( 1 ) : 81- 85.
  • 5WANG L J, REE S C, HUANG Y S, et al. Adjunctive effects of aripiprazole on metabolic profiles:comparison of patients treated with olanzapine to patients treated with other atypical antipsychotic drugs [ J ]. Prog Neuropsychopnarmacol Bid Psychiatry, 2013,40: 260-266.
  • 6ROERIG J L, STEFFEN K J, MITCHELL J E.Atypical anti- psychotic-induced weight gain: insights into mechanisms of action[J] .CNS Drugs,2011,25(12) : 1035-1059.
  • 7HEAL D J, GOSDEN J, JACKSON H C, et al. Metabolic consequences of antipsychotic therapy:preclinical and clinical perspectives on diabetes, diabetic ketoacidosis, and obesity [ J] .Handb Exp Pharmacol, 2012,212:135-164.
  • 8Kahn RS, Keefe RS. Schizophrenia is a cognitive illness : time for a change in tbcus[ Jl. JAMA Psychiatry, 2013,70(10) : 1107- 1112.
  • 9Bowie CR, Reichenberg A, Patterson TL, et al. Determinants of zal-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms [J]. Am J Psychiatry, 2006,163(3) :418-425.
  • 10Green MF, Nuechterlein KH, Kern RS, et al. Functional co- primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study[ J]. Am J Psyehiatry, 2008,165 ( 2 ) : 221-228.

共引文献260

同被引文献98

引证文献11

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部